John Darmawan

1.2k total citations
18 papers, 917 citations indexed

About

John Darmawan is a scholar working on Rheumatology, Hematology and Rehabilitation. According to data from OpenAlex, John Darmawan has authored 18 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 8 papers in Hematology and 5 papers in Rehabilitation. Recurrent topics in John Darmawan's work include Rheumatoid Arthritis Research and Therapies (11 papers), Autoimmune and Inflammatory Disorders Research (8 papers) and Spondyloarthritis Studies and Treatments (5 papers). John Darmawan is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Autoimmune and Inflammatory Disorders Research (8 papers) and Spondyloarthritis Studies and Treatments (5 papers). John Darmawan collaborates with scholars based in China, Japan and Indonesia. John Darmawan's co-authors include Shun Le Chen, Qing Yu Zeng, Zheng Yu Xiao, R. D. Wigley, Ren Chen, Jonathan Parker, Syed Atiqul Haq, Johannes J. Rasker, Md. Nazrul Islam and Mohammad Tahir and has published in prestigious journals such as Arthritis Research & Therapy, The Journal of Rheumatology and Clinical Rheumatology.

In The Last Decade

John Darmawan

18 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Darmawan China 13 568 188 185 182 133 18 917
K. Krüger Germany 15 372 0.7× 141 0.8× 51 0.3× 36 0.2× 48 0.4× 94 761
Ihsane Hmamouchi Morocco 20 503 0.9× 157 0.8× 89 0.5× 86 0.5× 30 0.2× 84 1.1k
R. Bahiri Morocco 19 531 0.9× 145 0.8× 145 0.8× 94 0.5× 18 0.1× 80 917
A. Andrianakos Greece 13 527 0.9× 140 0.7× 44 0.2× 83 0.5× 28 0.2× 18 739
Jacqueline Rodríguez-Amado Mexico 10 269 0.5× 106 0.6× 85 0.5× 69 0.4× 68 0.5× 14 426
Christophe Hudry France 18 843 1.5× 244 1.3× 73 0.4× 117 0.6× 24 0.2× 50 1.1k
Finbar O’Shea Ireland 21 719 1.3× 389 2.1× 109 0.6× 108 0.6× 14 0.1× 62 1.0k
William R. Felts United States 6 410 0.7× 59 0.3× 57 0.3× 145 0.8× 30 0.2× 8 692
Marcel Flendrie Netherlands 10 395 0.7× 174 0.9× 35 0.2× 45 0.2× 35 0.3× 34 731
W. Mau Germany 12 683 1.2× 205 1.1× 71 0.4× 57 0.3× 27 0.2× 32 816

Countries citing papers authored by John Darmawan

Since Specialization
Citations

This map shows the geographic impact of John Darmawan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Darmawan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Darmawan more than expected).

Fields of papers citing papers by John Darmawan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Darmawan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Darmawan. The network helps show where John Darmawan may publish in the future.

Co-authorship network of co-authors of John Darmawan

This figure shows the co-authorship network connecting the top 25 collaborators of John Darmawan. A scholar is included among the top collaborators of John Darmawan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Darmawan. John Darmawan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Haq, Syed Atiqul, Fereydoun Davatchi, Md. Nazrul Islam, et al.. (2010). Development of a questionnaire for identification of the risk factors for osteoarthritis of the knees in developing countries. A pilot study in Iran and Bangladesh. An ILAR–COPCORD phase III study. International Journal of Rheumatic Diseases. 13(3). 203–214. 39 indexed citations
2.
Zeng, Qing Yu, Ren Chen, John Darmawan, et al.. (2008). Rheumatic Diseases in China. Arthritis Research & Therapy. 10(1). R17–R17. 281 indexed citations
3.
Haq, Syed Atiqul, et al.. (2008). Incidence of musculoskeletal pain and rheumatic disorders in a Bangladeshi rural community: a WHO‐APLAR‐COPCORD study. International Journal of Rheumatic Diseases. 11(3). 216–223. 16 indexed citations
4.
Haq, Syed Atiqul, Johannes J. Rasker, John Darmawan, & Arvind Chopra. (2008). WHO‐ILAR‐COPCORD in the Asia‐Pacific: the past, present and future. International Journal of Rheumatic Diseases. 11(1). 4–10. 15 indexed citations
6.
Darmawan, John, Shun‐le Chen, Syed Atiqul Haq, et al.. (2006). Excellent endpoints from step-down bridge combination therapy of 5 immunosuppressants in NSAID-refractory ankylosing spondylitis: 6 year international study in Asia - WHO-ILAR COPCORD stage II treatment of the autoimmune diseases.. PubMed. 33(12). 2484–92. 6 indexed citations
7.
Muirden, Kenneth D., et al.. (2006). Characteristics of chronic gout in Northern Sulawesi, Indonesia.. PubMed. 33(9). 1813–7. 20 indexed citations
8.
Zeng, Qing Yu, John Darmawan, Zheng Yu Xiao, et al.. (2005). Risk factors associated with rheumatic complaints: a WHO-ILAR COPCORD study in Shantou, Southeast China.. PubMed. 32(5). 920–7. 22 indexed citations
9.
Haq, Syed Atiqul, et al.. (2005). Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study.. PubMed. 32(2). 348–53. 163 indexed citations
10.
Darmawan, John, et al.. (2004). Ten years radiographic outcome of rheumafactor positive rheumatoid arthritis patients treated with aggressive low dose immunosuppressive combination therapy.. The Journal of Rheumatology. 31(69). 66–69. 3 indexed citations
11.
Darmawan, John, et al.. (2004). Ten-year radiographic outcome in patients with rheumatoid factor positive rheumatoid arthritis treated with aggressive immunosuppressive combination therapy.. PubMed. 69. 66–9. 4 indexed citations
12.
Zeng, Qing Yu, Ren Chen, Zheng Yu Xiao, et al.. (2004). Low prevalence of knee and back pain in southeast China; the Shantou COPCORD study.. PubMed. 31(12). 2439–43. 59 indexed citations
13.
Parker, Jonathan, et al.. (2004). Rheumatic disease in an Australian Aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey.. PubMed. 31(5). 965–72. 106 indexed citations
14.
Darmawan, John, et al.. (2003). Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study.. PubMed. 30(10). 2252–6. 87 indexed citations
15.
Darmawan, John, et al.. (2003). The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years.. PubMed. 30(11). 2437–43. 22 indexed citations
16.
Darmawan, John, et al.. (2003). Reduced burden of disease and improved outcome of patients with rheumatoid factor positive rheumatoid arthritis compared with dropouts. A 10 year observational study.. PubMed. 67. 50–3. 10 indexed citations
17.
Darmawan, John, Marcos Bosi Ferraz, Kenneth D. Muirden, & Peter Tugwell. (1995). Case Study: World Health Organization-International League of Associations for Rheumatology Community-Oriented Programme for the Control of Rheumatic Diseases (WHO-ILAR COPCORD) in Indonesia and Brazil. International Journal of Technology Assessment in Health Care. 11(4). 700–708. 8 indexed citations
18.
Darmawan, John, et al.. (1995). Gout and hyperuricaemia. Baillière s Clinical Rheumatology. 9(1). 83–94. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026